Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Anti-glycation treatments might slow skin aging, but more research is needed.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Methotrexate may help stabilize frontal fibrosing alopecia.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.